These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2248 related items for PubMed ID: 32552762

  • 1. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, Li C, Sun L, Qin J, Xu T, He B, Pan Y, Sun H, Wang S.
    Mol Cancer; 2020 Jun 17; 19(1):106. PubMed ID: 32552762
    [Abstract] [Full Text] [Related]

  • 2. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
    Yang X, Zhang S, He C, Xue P, Zhang L, He Z, Zang L, Feng B, Sun J, Zheng M.
    Mol Cancer; 2020 Feb 28; 19(1):46. PubMed ID: 32111213
    [Abstract] [Full Text] [Related]

  • 3. METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.
    Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN, Chen ZH, Zeng ZL, Wang F, Zheng J, Chen D, Li B, Kang TB, Xie D, Lin D, Ju HQ, Xu RH.
    Mol Cancer; 2019 Jun 24; 18(1):112. PubMed ID: 31230592
    [Abstract] [Full Text] [Related]

  • 4. METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma.
    Liu Z, Sun T, Piao C, Zhang Z, Kong C.
    Cell Commun Signal; 2022 Mar 19; 20(1):36. PubMed ID: 35305660
    [Abstract] [Full Text] [Related]

  • 5. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner.
    Miao YQ, Chen W, Zhou J, Shen Q, Sun Y, Li T, Wang SC.
    Bioengineered; 2022 Jan 19; 13(1):1858-1871. PubMed ID: 35012429
    [Abstract] [Full Text] [Related]

  • 6. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J, Xie H, Ying Y, Chen H, Yan H, He L, Xu M, Xu X, Liang Z, Liu B, Wang X, Zheng X, Xie L.
    Mol Cancer; 2020 Oct 29; 19(1):152. PubMed ID: 33121495
    [Abstract] [Full Text] [Related]

  • 7. KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner.
    Ma L, Lin Y, Sun SW, Xu J, Yu T, Chen WL, Zhang LH, Guo YC, Wang YW, Chen T, Wei JF, Zhu LJ.
    Oncogene; 2022 Jan 29; 41(5):692-703. PubMed ID: 34819634
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
    Chen S, Yang C, Wang ZW, Hu JF, Pan JJ, Liao CY, Zhang JQ, Chen JZ, Huang Y, Huang L, Zhan Q, Tian YF, Shen BY, Wang YD.
    J Hematol Oncol; 2021 Apr 13; 14(1):60. PubMed ID: 33849617
    [Abstract] [Full Text] [Related]

  • 10. Methyltransferase like-14 suppresses growth and metastasis of non-small-cell lung cancer by decreasing LINC02747.
    Wang J, Wang S, Yang H, Wang R, Shi K, Liu Y, Dou L, Yu H.
    Cancer Sci; 2024 Sep 13; 115(9):2931-2946. PubMed ID: 38888105
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
    Liu T, Wang H, Fu Z, Wang Z, Wang J, Gan X, Wang A, Wang L.
    Cancer Sci; 2022 Feb 13; 113(2):446-458. PubMed ID: 34813676
    [Abstract] [Full Text] [Related]

  • 14. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
    Du C, Lv C, Feng Y, Yu S.
    J Exp Clin Cancer Res; 2020 Oct 21; 39(1):223. PubMed ID: 33087165
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.
    Zhang L, Luo X, Qiao S.
    Br J Cancer; 2022 Jul 21; 127(1):30-42. PubMed ID: 35249103
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.
    Wang M, Liu J, Zhao Y, He R, Xu X, Guo X, Li X, Xu S, Miao J, Guo J, Zhang H, Gong J, Zhu F, Tian R, Shi C, Peng F, Feng Y, Yu S, Xie Y, Jiang J, Li M, Wei W, He C, Qin R.
    Mol Cancer; 2020 Aug 25; 19(1):130. PubMed ID: 32843065
    [Abstract] [Full Text] [Related]

  • 19. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
    Wang X, Lu X, Wang P, Chen Q, Xiong L, Tang M, Hong C, Lin X, Shi K, Liang L, Lin J.
    J Transl Med; 2022 May 04; 20(1):198. PubMed ID: 35509101
    [Abstract] [Full Text] [Related]

  • 20. SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis.
    Du F, Chen J, Liu H, Cai Y, Cao T, Han W, Yi X, Qian M, Tian D, Nie Y, Wu K, Fan D, Xia L.
    Cell Death Dis; 2019 Mar 11; 10(3):239. PubMed ID: 30858360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 113.